Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 5, 2004, Pages

  Zoccali, Carmine ^a,b   Mallamaci, Francesca ^a   Tripepi, Giovanni ^a  

^a Riuniti Hospital   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Adipocytes; Cardiovascular; Cardiovascular disease; Cytokines; End stage renal disease; Inflammation; Predictors; Risk; Uraemia

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROTECTION; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; ENDOTHELIUM; HEART PROTECTION; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE; METABOLIC DISORDER; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVAL TIME;

ADIPOCYTES; CYTOKINES; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 4544229847     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1059     Document Type: Review

References (17)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
2. Kurrelmeyer KM, Michael LH, Baumgarten G et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000; 97: 5456-5461
3. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247-1252
4. Sivasubramanian N, Coker ML, Kurrelmeyer KM et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001; 104: 826-831
5. Vasan RS, Sullivan LM, Roubenoff R et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003; 107: 1486-1491
6. Kimmel PL, Phillips TM, Simmens SJ et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-244
7. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688
8. Anon. C-reactive protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant 1998; 13: 2710-2711
9. Zimmermann J, Herlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
10. Stenvinkel P, Wanner C, Metzger T et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 2002; 62: 1791-1798
11. Zoccali C, Mallamaci F, Tripepi G et al. Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med 2003; 254: 132-139
12. Girndt M, Kaul H, Sester U et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949-955
13. Stefoni S, Cianciolo G, Donati G et al. Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 2002; 61: 324-335
14. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599
15. Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126-1133
16. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476
17. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141